Intent to Reissue MIRA Funding Opportunity Announcement for Early Stage Investigators (R35)

I’m pleased to announce that the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for early stage investigators (ESIs) will be reissued in the spring of 2023. MIRA provides support for a research program in an ESI’s laboratory that falls within the NIGMS mission. For details, see NOT-GM-23-017.  The reissued FOA will essentially be the same as the previous one, with a couple of minor changes: There will be two application receipt dates per year—February and October.Applications must include a plan for enhancing diverse perspectives, which is a new requirement for this FOA. Important Note: MIRA FOA PAR-22-180 funding is limited to eligible NIGMS-funded investigators and new investigators. Current ESIs should not apply to PAR-22-180. ESI MIRA applications will be reviewed separately from MIRA applications submitted to PAR-22-180.
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - Category: Biomedical Science Authors: Tags: Funding Opportunities Early Stage Investigator MIRA Source Type: blogs